Shlomo Melmed
Department of Medicine
Cedars-Sinai Medical Center
Los Angeles
USA
Name/email consistency: high
- Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension. Melmed, S., Cook, D., Schopohl, J., Goth, M.I., Lam, K.S., Marek, J. Pituitary (2010)
- Current status and future opportunities for controlling acromegaly. Melmed, S., Vance, M.L., Barkan, A.L., Bengtsson, B.A., Kleinberg, D., Klibanski, A., Trainer, P.J. Pituitary (2002)